论文部分内容阅读
目的:利用AMSTAR、PRISMA两种方法学质量评价工具评估肺癌相关治疗性系统评价或Meta分析文献的质量。方法:电子检索中国期刊全文数据库(CNKI)、维普中文科技期刊全文数据库(VIP)、万方医药期刊全文数据库等数据库,并辅以手工检索,检索时间为2001年1月至2011年12月,分别采用AMSTAR、PRISMA量表评估肺癌治疗相关系统评价的质量,采用SPSS 16.0进行统计分析。结果:最终纳入74篇文献进行质量评价,85.1%方法学质量评价在6分以下,71.6%报告质量评价大多在13分以下。结论:肺癌相关性系统评价或Meta分析在方法学质量和报告质量两方面均普遍较低,需引起重视,进一步改进与提高。
OBJECTIVE: To assess the quality of the literature on therapeutic or meta-analysis of lung cancer using the AMSTAR and PRISMA methodologies. Methods: The databases of Chinese Periodicals Full Text Database (CNKI), VIP Chinese Scientific Periodicals (VIP) and Wanfang Medicine Periodicals Full - text Database were electronically searched and retrieved manually. The retrieval time ranged from January 2001 to December 2011, The AMSTAR and PRISMA scales were respectively used to evaluate the quality of lung cancer treatment-related systematic reviews. SPSS 16.0 was used for statistical analysis. Results: 74 articles were finally included for quality evaluation, 85.1% methodological quality evaluation was below 6 points, and 71.6% reporting quality evaluation was mostly below 13 points. CONCLUSIONS: Systematic reviews or meta-analyzes of lung cancer-related systems are generally low in terms of both methodological quality and reporting quality, requiring attention and further improvement and improvement.